Document Information
Quality Indicators for Dementia in Vulnerable Community-Dwelling and Hospitalized Elders
Dementia is defined by acquired, progressive impairment in two or more cognitive areas (for example, frontal executive function, mood, or memory) that is severe enough to render a person dependent on others. Dementia is a leading cause of disability among older adult patients; Alzheimer disease is the most common etiology. The prevalence of Alzheimer disease is approximately 2% among persons 60 to 64 years of age, and the prevalence increases exponentially every 5 years thereafter, reaching 40% among persons older than 80 years of age. The prevalence of the other common dementias, including vascular dementia, the combination of Alzheimer disease and vascular dementia, and dementia with Lewy bodies, ranges from 15% to 20%. The incidence of Alzheimer disease is approximately 266 000 cases per year. Because the older adult population will grow 50% over the next three decades, the need for dementia care will increase significantly. Alzheimer disease and vascular dementia are contributory causes of death among 19% of elders older than 85 years of age, decreasing life expectancy by to 4 years. The mortality rate among patients with newly diagnosed Alzheimer disease is twice that seen in age-matched, nonaffected persons in the community. Dementia is the most common reason for placement of older adults in nursing facilities. The advent of pharmacotherapy to forestall cognitive decline presents new opportunities to reduce disability during the course of Alzheimer disease and related dementias. This paper presents indicators to assess the quality of care for patients with dementia. Methods: The methods for developing these quality indicators, including literature review and expert panel consideration, are detailed in another paper in this issue. For dementia, the structured literature review identified 2277 titles, from which abstracts and articles relevant to this report were identified. On the basis of the literature and the authors' expertise, 30 potential quality indicators were proposed. Results: Of the 30 potential quality indicators, 14 were judged to be valid by the expert panel process 3 were folded into other indicators, and 13 were not accepted.
Free, downloadable PDF file(s) are available below.
RAND makes an electronic version of this document available for free as a public service.
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
Originally published in: Annals of Internal Medicine, v. 135, no. 8, pt. 2, October 16, 2001, pp. 668-676.
This product is part of the RAND Corporation reprint series. RAND reprints present previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints have been formally reviewed in accordance with the publisher's editorial policy, and are compliant with RAND's rigorous quality assurance standards for quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.


Top